AMP Capital Investors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-21,300
| Closed | -$1.56M | – | 12 |
|
|
2022
Q1 | $1.56M | Buy |
+21,300
| New | +$1.43M | 0.07% | 76 |
|
|
2021
Q4 | – | Sell |
-584,451
| Closed | -$34.6M | – | 308 |
|
|
2021
Q3 | $34.6M | Sell |
584,451
-107,104
| -15% | -$7.05M | 0.19% | 132 |
|
|
2021
Q2 | $46.2M | Sell |
691,555
-44,981
| -6% | -$2.93M | 0.22% | 115 |
|
|
2021
Q1 | $46.5M | Sell |
736,536
-147,929
| -17% | -$9.2M | 0.23% | 107 |
|
|
2020
Q4 | $54.8M | Buy |
884,465
+7,193
| +0.8% | +$442K | 0.29% | 76 |
|
|
2020
Q3 | $52.5M | Buy |
877,272
+68,991
| +9% | +$4.15M | 0.31% | 69 |
|
|
2020
Q2 | $46.7M | Buy |
808,281
+32,226
| +4% | +$1.93M | 0.29% | 82 |
|
|
2020
Q1 | $42.2M | Sell |
776,055
-100,448
| -11% | -$6.14M | 0.31% | 74 |
|
|
2019
Q4 | $55.9M | Buy |
876,503
+288,360
| +49% | +$16.5M | 0.31% | 76 |
|
|
2019
Q3 | $29.5M | Sell |
588,143
-187,035
| -24% | -$8.79M | 0.16% | 157 |
|
|
2019
Q2 | $35M | Sell |
775,178
-130,876
| -14% | -$6.1M | 0.19% | 128 |
|
|
2019
Q1 | $43.3M | Sell |
906,054
-79,182
| -8% | -$3.94M | 0.25% | 104 |
|
|
2018
Q4 | $50.2M | Buy |
985,236
+87,513
| +10% | +$4.7M | 0.32% | 75 |
|
|
2018
Q3 | $55.6M | Sell |
897,723
-70,403
| -7% | -$4.18M | 0.3% | 77 |
|
|
2018
Q2 | $53.6M | Buy |
968,126
+287,159
| +42% | +$15.5M | 0.3% | 76 |
|
|
2018
Q1 | $42.6M | Sell |
680,967
-158,060
| -19% | -$10.2M | 0.24% | 108 |
|
|
2017
Q4 | $51.4M | Buy |
839,027
+37,702
| +5% | +$2.36M | 0.28% | 90 |
|
|
2017
Q3 | $51.1M | Buy |
801,325
+175,983
| +28% | +$10.3M | 0.29% | 91 |
|
|
2017
Q2 | $34.9M | Buy |
625,342
+83,912
| +15% | +$4.57M | 0.21% | 120 |
|
|
2017
Q1 | $30M | Sell |
541,430
-11,254
| -2% | -$617K | 0.18% | 132 |
|
|
2016
Q4 | $32.6M | Sell |
552,684
-23,047
| -4% | -$1.26M | 0.2% | 114 |
|
|
2016
Q3 | $31M | Buy |
575,731
+33,420
| +6% | +$2.15M | 0.19% | 121 |
|
|
2016
Q2 | $39.6M | Sell |
542,311
-13,578
| -2% | -$959K | 0.26% | 85 |
|
|
2016
Q1 | $35.3M | Sell |
555,889
-60,740
| -10% | -$3.83M | 0.24% | 102 |
|
|
2015
Q4 | $42.9M | Sell |
616,629
-67,098
| -10% | -$4.43M | 0.29% | 83 |
|
|
2015
Q3 | $40.3M | Sell |
683,727
-19,673
| -3% | -$1.25M | 0.29% | 77 |
|
|
2015
Q2 | $46.4M | Buy |
703,400
+59,338
| +9% | +$3.91M | 0.3% | 82 |
|
|
2015
Q1 | $42.4M | Buy |
644,062
+10,569
| +2% | +$662K | 0.26% | 92 |
|
|
2014
Q4 | $37.6M | Sell |
633,493
-131,076
| -17% | -$7.39M | 0.23% | 105 |
|
|
2014
Q3 | $39.5M | Sell |
764,569
-19,047
| -2% | -$951K | 0.25% | 99 |
|
|
2014
Q2 | $38.4M | Buy |
783,616
+181,173
| +30% | +$8.93M | 0.24% | 103 |
|
|
2014
Q1 | $31.2M | Buy |
602,443
+132,410
| +28% | +$7.05M | 0.21% | 107 |
|
|
2013
Q4 | $25.1M | Sell |
470,033
-33,352
| -7% | -$1.7M | 0.18% | 139 |
|
|
2013
Q3 | $23.3M | Sell |
503,385
-52,099
| -9% | -$2.29M | 0.18% | 138 |
|
|
2013
Q2 | $25.7M | Buy |
+555,484
| New | +$24.1M | 0.2% | 114 |
|
Other funds holding BMY
AMP Capital Investors's BMY Position: Q2 2022 in Review
AMP Capital Investors sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 21,300 shares — an estimated $1.56M sold.
AMP Capital Investors first reported a position in BMY in Q2 2013 and held it in 35 quarters. The position peaked at $55.9M in Q4 2019. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.
- AMP Capital Investors reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
- AMP Capital Investors sold 21,300 Bristol-Myers Squibb shares in Q2 2022, an estimated $1.56M.
- AMP Capital Investors first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 35 quarters.
- AMP Capital Investors's Bristol-Myers Squibb position peaked at $55.9M in Q4 2019.
- 2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.
Based on AMP Capital Investors's 13F filing for Q2 2022.